Table 1.
Clinical characteristics of probands who underwent genetic testing (N = 460).
Table 2.
Test strategy (N = 460).
Fig 1.
Proportion of pathogenic mutations detected in BRCA1/2 and non-BRCA1/2 genes.
Table 3.
Factors associated with increased odds of harboring a pathogenic mutation (N = 460).
Fig 2.
Proportion of pathogenic mutations detected in BRCA1/2 and non-BRCA1/2 genes by Ethnicity (N = 419).
(Excluding n = 41 probands who underwent predictive testing) Proportion of Pathogenic Mutations by Ethnicity.
Fig 3.
Distribution of variants of uncertain significance (VUS) detected in 125 probands.
VUS Count by Gene.